Clinical evaluation local ocular anticholinesterase agents in myasthenia gravis.
作者信息
GILES C L, WESTERBERG M R
出版信息
Am J Ophthalmol. 1961 Sep;52:331-40. doi: 10.1016/0002-9394(61)90729-2.
PMID:13705283
Abstract
摘要
相似文献
1
Clinical evaluation local ocular anticholinesterase agents in myasthenia gravis.
Am J Ophthalmol. 1961 Sep;52:331-40. doi: 10.1016/0002-9394(61)90729-2.
2
Local administration of anticholinesterase agents in ocular myasthenia gravis.
Arch Ophthalmol. 1960 Mar;63:544-7. doi: 10.1001/archopht.1960.00950020546012.
3
The long-acting anticholinesterase drugs in the management of myasthenia gravis.长效抗胆碱酯酶药物在重症肌无力治疗中的应用
J Chronic Dis. 1957 Nov;6(5):457-74. doi: 10.1016/0021-9681(57)90037-1.
4
Treatment of anticholinesterase intoxication with oximes; use in normal subjects and in patients with myasthenia gravis.肟类药物治疗抗胆碱酯酶中毒；在正常受试者和重症肌无力患者中的应用。
J Am Med Assoc. 1958 Apr 12;166(15):1855-8. doi: 10.1001/jama.1958.62990150001011.
5
Myasthenia gravis with ocular involvement in older patients.
Can J Ophthalmol. 2001 Feb;36(1):26-33. doi: 10.1016/s0008-4182(01)80063-6.
6
[On the mechanism of action of some anticholinesterase preparations].[关于某些抗胆碱酯酶制剂的作用机制]
Biull Eksp Biol Med. 1962 May;53:76-80.
7
Treatment of myasthenia gravis: an audit.
Q J Med. 1987 Aug;64(244):693-704.
8
9
Ocular myasthenia gravis.眼肌型重症肌无力
J Natl Med Assoc. 1993 Sep;85(9):681-4.
10
Ocular myasthenia gravis.眼肌型重症肌无力
Curr Opin Ophthalmol. 1996 Dec;7(6):39-41. doi: 10.1097/00055735-199612000-00006.
Zotero 插件